Tumori, Ail Milano Monza Brianza: 50 Years with Patients and for Onohaematological Research
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.5 Articles
5 Articles
Rome, 28 Sep. • It will be held Friday 2 October 2026 at the Istituto dei Ciechi in Milan in Via Vivaio 7 a meeting organized by AIL Milano Monza Brianza on the occasion of the first 50 years of activity of the Association. A moment of reflection with some of the protagonists of the past and the present that will see the presence of [...]
On the occasion of the first 50 years of activity of the Italian Association against lymphoma and myeloma leukemia, the Ail Milano Monza Brianza organizes, Friday, October 2, a moment of reflection with some of the protagonists of the past and the present, experts in research and treatment of oncoematological diseases and with the testimony of patients and volunteers. The meeting [...]
Rec News | Lontani dal mainstream
notizie.itOn the occasion of the first 50 years of activity of the Italian Association against lymphoma and myeloma leukemias, the Ail Milano Monza Brianza organizes, Friday 2 October, a moment of reflection with some of the protagonists of the past and the present, experts in the research and treatment of oncoematological diseases and with the testimony of patients and volunteers. The meeting [...] L'articolo Tumori, Ail Milano Monza Brianza: 50 years wi…
On October 2, 2026 AIL Milano Monza Brianza celebrates its first 50 years with a meeting dedicated to the progress of onco-haematological research and its commitment alongside patients. To share its history and challenges for the future together with doctors, researchers, volunteers, supporters and institutions. It will be held on Friday, October 2, 2026 [...] L'articolo AIL Milano Monza Brianza: 50 years next to patients "Research, Care, Future…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
